本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

25.73
+1.305.32%
盤後25.730.00000.00%19:34 EDT
成交量:206.97萬
成交額:5,286.27萬
市值:17.69億
市盈率:-10.71
高:25.88
開:24.58
低:24.40
收:24.43
52周最高:40.65
52周最低:12.38
股本:6,875.59萬
流通股本:4,433.30萬
量比:1.62
換手率:4.67%
股息:- -
股息率:- -
每股收益(TTM):-2.4031
每股收益(LYR):-2.0125
淨資產收益率:-45.31%
總資產收益率:-28.46%
市淨率:5.00
市盈率(LYR):-12.79

資料載入中...

2024/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/19

SEC問詢函

Form CORRESP - Correspondence
2024/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report